Background and aims: There are 9 million people suffering from brain vascular diseases in the world. The main place belongs to the stroke of more than 6.6 million people. Despite the previous conclusions about the inefficiency of surgical brain revascularization under the conditions of ishemic stroke (1988), the latest research works prove their clinical expediency.
Purpose: The purpose of work was the analysis of treatment results of patients with the chronic cerebral ishemia caused by plural impacts of the main arteries of a brain. Methods: Are presented by 18 patients with plural stenosis and occlusion effects of carotids which had 20 extra-intracranial microvascular anastamoses (EC-IC bypass). The median age of the patients was 54 years. The estimation of total neurological deficiency of the patients was carried out with the use of the scale of ishemic stroke NIHSS consequences. The complex tool research included: TCDG with defining cerebrovascular reserves, duplex scanning of extracranial arteries, CTA, MRA and in some cases a DSA (angiography). Operations were performed under the general anesthesia with the use of an operational microscope. All patients had a two-sided effect of the carotid pool. In 16 cases (88.9%) there were post-thrombotic occlusion of the internal carotid from one side in the combination with a hemodynamically significant stenosis or a pathological deformation from the opposite side. For these patients an EC-IC bypass on the side of occlusion was performed. In two cases (11.1%) post-thrombotic occlusions of both carotids was diagnosed which required the creation EC-IC bypass from both sides. Results: There were the recourse of attributes of a cerebral ishemia according to the scale NIHSS, and also authentic increase of the total brain blood-flow and normalization of autoregulation parameters of cerebral hemodynamics (15 patients-83.3%). There were complications of surgical treatment in two cases (11,1%). One patient had epidural hematoma which required its emergency removal. In another case there was an increase of neurological deficiency during the operation. During the control inspections the thrombosis of microanastomosis (inconsistency) was revealed in one case (catamnesis-5 years). Conclusions: The creation of EC-IC bypass of the bicarotid is an effective revasculation operation in cases of its performance on the side of clinical symptomatic prevalence, provide good condition of cerebral reserves and well passable external carotid.
CBF effects of brain preconditioning produced by cortical lesions

L. Zhao and T. Nowak
Department of Neurology, University of Tennessee Health Science Center, Memphis, Tennessee, USA Aims: Diverse phenomena of brain preconditioning have been described, including effects of brief focal ischemia or discrete cortical lesions to reduce infarct volume following subsequent middle cerebral artery (MCA) occlusion. Ischemic preconditioning has been associated with early CBF recovery in penumbra during the initial hours of subsequent permanent MCA occlusion that predicted eventual infarct volume (Zhao and Nowak, J Cereb Blood Flow Metab 2006; 26:1128-1140). The current study examined CBF responses and peri-infarct depolari-zations in brain preconditioned by a prior cortical cold lesion (CL). Methods: Small cortical lesions were produced in male Spontaneously Hypertensive Rats (SHR) under isoflurane anesthesia by application of a 2 mm diameter liquid nitrogen-chilled metal probe to the thinned skull overlying MCA territory. Sham animals experienced surgical preparation without freezing. The following day rats were subjected to permanent focal occlusion of the MCA and ipsilateral common carotid artery. Infarct volumes were determined at 24 h in hematoxylin-eosin stained frozen sections. CBF was also monitored by C14-iodoantipyrine autoradiography at various time points after occlusion, or throughout the initial hours of occlusion by speckle contrast perfusion imaging with simultaneous electrophysiological recording. Results: Edema-corrected infarct volumes were 116±14, 113±11 and 85±14 cubic mm in Naïve, Sham and CL groups (mean ± SD; n = 9, 10, and 10), respectively, demonstrating the efficacy of preconditioning by prior lesions. The CBF deficit at 15 mins after occlusion was unaffected by CL, but volumes of severely ischemic territory (CBF less than 30 mL/ 100 g/mins) at 3 h after occlusion were 130±8, 113± 10 and 67±19 cubic mm (n = 5, 4, and 7) in these groups, establishing a phenomenon of early CBF improvement identical to that previously observed after ischemic preconditioning. The magnitude of protection was independent of CL size in the range 2-8 cubic mm. Peri-infarct depolarizations were associated with propagated waves of hyperemia detected by perfusion imaging. These events were completely eliminated in animals with CL larger than 5 cubic mm. However, their incidence was also decreased in animals with smaller, still protective lesions to an extent comparable to that observed after sham surgery. Excluding rats with large lesions, median depolarization numbers during 4 h of occlusion in Naïve, Sham and CL groups were 7 (range 5-11, n = 5), 4 (range 1 to 5, n = 6) and 4 (range 3 to 5, n = 7), respectively. Conclusions: Cortical lesions produce preconditioning mechanistically identical to that induced by prior ischemia, since both are associated with early CBF recovery. CL also reduces the number of Peri-infarct depolarizations, although sham surgery had a comparable effect, indicating that such attenuation is not by itself sufficient for protection. The potential contribution of decreased depolarization number to subsequent CBF recovery and infarct volume reduction remains to be established. Objectives: Preconditioning with mild hypoxia and the hypoxia-mimetic compounds desferrioxamine (DFX) and cobalt chloride (CoCl 2 ) have been shown to have protective actions against a subsequent hypoxic-ischaemic (HI) brain insult. These treatments alone are not sufficient to cause neuronal injury, but can induce changes in gene expression and intracellular signalling pathways. The expression of the hypoxia-inducible transcription factor (HIF-1) 1 and several HIF-1 target genes 2 are upregulated after preconditioning with hypoxia and mimetics in neonatal rat brain. Interestingly, many HIF-1 target genes (including erythropoietin and VEGF) have been shown to increase cell proliferation in the brain. 3 We have investigated whether preconditioning treatments that can increase HIF-1 have long lasting neuroprotective actions and alter cell proliferation up to 5 weeks after an HI insult. Methods: Sprague Dawley rats (postnatal day 6 (p6)) were exposed to preconditioning with hypoxia (3 h, 8% oxygen), normoxia (3 h, room air) or injected with DFX (200 mg/kg, i.p.) or CoCl 2 (60 mg/kg, i.p.). On p7, all pups were subjected to HI or sham surgery. Bromodeoxyuridine (BrdU, 50 mg/kg, i.p.) was injected twice daily for 3 days following surgery and was used to examine cell proliferation. At 5 weeks after HI insult, brains were collected for imunohistochemical and histological processing.
Hypoxic preconditioning reduces hypoxia-ischemia-induced cell proliferation in the rat subventricular zone
Results: Hypoxia, DFX and CoCl 2 preconditioning all significantly reduced the extent of brain injury after HI insult as measured using Nissl staining and MCID analysis. Cell proliferation was examined using immunohistochemistry for BrdU and cell counts were obtained from the subventricular zone (SVZ). HI alone significantly increased (by 106%) the number of BrdU positive cells in SVZ compared to sham operated controls. Preconditioning with hypoxia and DFX performed 24 h prior to HI, reduced cell proliferation in SVZ by 28% and 33%, respectively, compared to animals which received HI alone. CoCl2 preconditioning had no effect on HI-induced cell proliferation in the SVZ. Interestingly, treatment with DFX alone, significantly increased the number of BrdU positive cells in SVZ compared to controls by 172%. Conclusions: Modulation of HIF-1 and its target genes is likely to be involved in the brain plasticity and neuroprotective effects conferred by preconditioning with hypoxia, DFX and CoCl 2 in neonatal rat brain.
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Longitudinal MRI characterization of stroke in ischemia tolerant rats
Objectives: The individual vulnerability to ischemia has a significant impact on tissue damage and outcome in stroke patients. Therapeutic interventions could be much better tailored to the patient if information about the individual resistance to ischemic injury was available. Tolerance to ischemia can be induced experimentally by 'preconditioning'. One preconditioning model that has been used to render the brain more tolerant to ischemia is the injection of 3-nitroproprionic acid (3NPA), a respiratory chain inhibitor. We used longitudinal MRI in adult rats to characterize how preconditioning with 3NPA affects the development of a stroke lesion and if a typical 'MRI signature' of preconditioned tissue can be extracted from these data. Methods: Adult Wistar rats received i.p. injections of 20 mg/kg 3NPA or saline and were subjected to transient (60 min) middle cerebral artery occlusion (MCAO) three days later. MR images were acquired during the occlusion (day 0) and after reperfusion (days 1, 4, 14). Quantitative CBF maps were obtained using flow-sensitive alternating inversion recovery (FAIR) arterial spin labeling with the QUIPSSII modification. In addition, diffusionweighted (DWI) images, T1 and T2 maps and anatomical T2w images were obtained. Functional deficits were assessed at each time point using a modified neurologic deficit scale. Brains were analyzed using immunofluorescence and immunohistochemical techniques.
Results: At 15 mins after insertion of the occluding device, the extent of the initial lesion on apparent diffusion coefficient (ADC) maps was similar between groups. Over the next 30 min of MCAO, however, there was a remarkable ADC recovery in the 3NPA group (Figure 1 ). During MCAO, preconditioned animals had fewer voxels with severely compromised CBF than controls. CBF on the unaffected side was lower in the 3NPA group during ischemia. A similarly low CBF was also found in 3NPA-preconditioned animals without stroke (data not shown). On day 14, infarcts were smaller and functional deficits less severe in the 3NPA group. However, rescue of neurons on the ischemic side was incomplete in 3NPA animals. There were no signs of tissue necrosis similar to controls, but in the ipsilateral striatum and layers II-III of the somatosensory cortex, selective neuronal death, gliosis and a mild inflammatory infiltrate were detected. Conclusions: Even with a large initial lesion on ADC maps, tissue recovery was substantial in 3NPApreconditioned animals. This was associated with a better functional outcome. On MRI, the 3NPA group showed higher intra-ischemic residual CBF, rapid intra-ischemic ADC recovery, less structural damage over time (depicted on fractional anisotropy, T2-w and T1-w images) and lower CBF values on the unaffected hemisphere. The latter could indicate vascular/metabolic adjustments of ischemia tolerance. Thus, MRI might have the potential to discriminate ischemia tolerant from vulnerable brains. Objectives: Preconditioning to mild systemic hypoxia two days prior to transient middle cerebral artery occlusion (tMCAo) significantly reduces injury. 1 We found that a series of repetitive hypoxic preconditioning (RHP) stimuli extends the duration of ischemic tolerance for many weeks, concomitant with reductions in post-stroke leukocyte-endothelial adherence. 2 As chemokines regulate inflammatory neutrophil chemotaxis, the present study investigated chemokine participation-specifically, the role of the anti-inflammatory chemokine CXCL12 (SDF-1) 3 -in establishing the ischemia-tolerant phenotype. We examined spatio-temporal responses of CXCL12a/b (two splice variants identified at the mRNA level only) and one of its receptors, CXCR4, to single hypoxic preconditioning (SHP) and RHP, and to tMCAo with and without prior RHP. Methods: Adult, male SW/ND4 mice were sacrificed 6, 12, or 24 h, 2 d, or 2 wks after SHP (4 h, 8%O 2 ) or RHP (9 exposures over 2 wks; 8% or 11%O 2 ; 2 or 4 h). Additional mice were sacrificed 24 h after 60-mins tMCAo 2 d, or 2 or 4 wks after RHP (n = 6/group). Cortical whole brain homogenates and capillary-rich fractions (isolated by differential centrifugation) were analyzed for CXCL12/CXCR4 message and protein expression by rtPCR (n = 8/group) and immunoblot (n = 4/group), or brains were sectioned for cellular localization by immunohistochemistry (n = 3/group). One-way ANOVA determined significance (P < 0.05). Results: CXCL12a mRNA increased four-fold (P < 0.05), and CXCR4 mRNA doubled (P < 0.01), in whole brain 12 h after SHP, returning to baseline at 2 d, a time when capillary expression of both CXCL12a and CXCR4 mRNA transiently doubled (P < 0.05). Neither whole brain nor capillary expression of CXCL12a or CXCR4 mRNA was elevated following RHP. SHP doubled CXCL12b mRNA (P < 0.01) by 2 d in brain, but not capillaries; following RHP, this elevated expression in whole brain was maintained through 2 wks (P < 0.05). RHP elevated brain CXCL12 protein at 2 d and 2 wks. CXCL12 and CXCR4 co-localized to neurons and endothelial cells, with strong peri-endothelial CXCL12 immunoreactivity after RHP. From 2 d to 4 wks following tMCAo, capillary CXCL12b mRNA, but not CXCL12a or CXCR4 mRNA, declined by half (P < 0.05) in mice with RHP relative to untreated ischemic controls.
Conclusions:
The tightly-coupled, transient upregulation of CXCL12a/CXCR4 mRNA expression 4 after SHP may initiate growth factor-and angiogenesisrelated gene expression changes 3 that likely contribute to ischemic tolerance; lack of a similar upregulation following RHP could reflect tachyphylaxis. The sustained increases in CXCL12b mRNA and protein in whole brain, elevated through 2 wks after RHP and localized to the peri-vascular space, may strengthen the blood-brain barrier prior to stroke. 5 Post-stroke reductions in capillary CXCL12b expression are consistent with an anti-inflammatory phenotype at the endothelial-blood interface, lowering leukocyte recruitment and endothelial adherence in preconditioned animals. 4 Thus, these changes support roles for this chemokine ligand/ receptor pair in establishing and maintaining the anti-inflammatory, ischemia-tolerant phenotype. Causal studies with pharmacologic inhibitors and in conditional knockout mice are underway.
preconditioning mechanisms depend on sphingosine kinase (SphK)-1. 2 Recent work in the brain documented a heterogeneous distribution of SphK isoform activity in normal and ischemic brain suggesting bioactive lipid signaling may differ from other organs. 3 Our preliminary studies indicate that, in the cerebral microvasculature, HPC leads to increased SphK2 protein expression, peaking 2 to 4 h after preconditioning, without a concomitant change in the protein levels of the SphK1 isoform.
Objectives: The present study was undertaken to document that increased microvascular SphK2 activity in response to HPC is vital to the mechanism of HPC-induced tolerance to focal cerebral ischemia.
We also sought to confirm SphK2-dependent protection of the blood-brain barrier in the HPC-induced ischemia-tolerant brain.
Methods: Temporal changes in microvascular SphK activity were measured following HPC using an established assay. 4 The nonselective SphK inhibitor dimethylsphingosine (DMS, 0.33 mg/kg, i.v.) was administered to adult male Swiss-Webster ND4 mice by retroorbital injection 30 min prior to HPC (4 h of 8% oxygen, systemic). Two days later, mice were subjected to a 60-min transient middle cerebral artery occlusion (tMCAO) under halothane anesthesia by the intraluminal suture method. After 24 h of reperfusion, neurological deficit was determined, and infarct volume was measured using TTC staining in conjunction with ipsilateral hemispheric swelling. In a separate set of mice, neurological deficit and vasogenic edema (brain water content) were assessed at 24 h of reperfusion.
Results: Microvascular SphK2 activity increased following HPC, while SphK1 was unchanged (which paralleled the microvascular protein expression levels of these respective isoforms we observed earlier). Reductions in infarct volume, neurological deficit, hemispheric swelling, and vasogenic edema in HPC-treated mice were abrogated when SphK was inhibited during HPC. Administering the SphK2 agonist FTY720 (0.24 mg/kg, i.p.) as an HPC mimic did not promote ischemic tolerance alone, but when combined with HPC, provided even greater (DMSreversible) protection of the neurovascular unit, suggesting that HPC-induced increases in SphK2 activity, not additional substrate, are needed as an induction signal for ischemic tolerance.
Conclusions: These findings indicate that sphingosine-1-phosphate, formed by hypoxia-sensitive increases in SphK2 activity, serves as a proximal signaling mediator that ultimately leads to alterations in gene expression and the promotion of an ischemia-tolerant vasculoprotective phenotype. Thus, components of this bioactive lipid signaling pathway may be suitable therapeutic targets for protecting the blood-brain barrier and neurovascular unit in stroke.
Objectives: Preconditioning is a procedure where exposure to a mild insult renders tissue less vulnerable to injury following a subsequent, more severe insult. Hypothermia is a conditioning procedure that has minimal risk of injury to brain tissue. This investigation had two major objectives:
(1) determine whether preconditioning hippocampal slices with hypothermia could induce rapid tolerance to a subsequent episode of severe hypoxia, and (2) determine whether rapid tolerance to severe hypoxia is mediated by erythropoietin (EPO) and its downstream signaling cascade.
Methods: Sprague-Dawley rats were anesthetized with ether, decapitated, and the brain was placed in buffered saline at 01C for 10 mins. 400 mm slices of hippocampus were cut with a manual chopper and slices were either placed in an interface recording chamber at 351C to 361C (normothermia) or in a preincubation chamber at 221C to 231C (hypothermia). Orthodromic population spikes evoked in CA1 were used to verify slice viability. Thereafter, the recording electrode was moved to the inner blade of the dentate gyrus to monitor the extracellular potential. Light transmittance (LT) was measured as an index of tissue swelling/depolarization either in the whole slice, using a dissecting microscope with a digital video camera attached to one eyepiece (Kreisman et al, 2000), or in the dentate gyrus with a photodiode. After two hours of incubation in 95% O 2 + 5% CO 2 (normoxia) normothermic slices were exposed to 10 min of hypoxia (95% N 2 + 5% CO 2 ). Normothermic slices were removed from the recording chamber and replaced with hypothermic slices, which were then incubated for 60 min at 351C-361C before being exposed to 10 min of hypoxia. Comparisons were made of the LT index of hypoxic swelling in normothermic slices versus slices preconditioned with hypothermia.
Results: Slices preconditioned with hypothermia (n = 11) had a 46.9% decrease in the LT index of swelling in response to 10 min of hypoxia, compared to normothermic slices (n = 12). Swelling was prevented completely in the CA3 region and parts of the dentate gyrus. The tolerance mediated by hypothermia was mimicked by bathing normothermic slices (n = 12) in recombinant rat EPO (10 ng/ml), which decreased the LT index of hypoxic swelling by 38.8% (P < 0.01 by Student's T test). Wortmannin (0.1 mmol/L), which blocks activation of Akt by PI3 kinase (downstream of the EPO receptor) reduced the tolerance mediated by hypothermic conditioning, as indicated by a decrease in the LT index of hypoxic swelling from 44.7% to 17.1% (n = 10).
(1) Hypothermic preconditioning produces rapid tolerance to subsequent hypoxic injury in hippocampal slices. Background: Recent studies suggest that dietary virgin olive oil results in ischemic tolerance to reduce brain ischemia injury in rat brain slices. In this research, we attempted to investigate effects of virgin olive oil pretreatment against ischemiareperfusion injury to the rat brain tissue. Methods: Experimental rats were treated orally with virgin olive oil for 30 days at 0.25, 0.5 and 0.75 ml/ kg/day (doses A, B and C, respectively). Control group treated with saline for 30 days. At the end of day 30, each group was exposed to middle cerebral artery occlusion for 60 min. Objectives: Ischemic preconditioning (IPC) is an endogenous protective mechanism invoked by a brief, sublethal ischemic insult prior to a subsequent lethal ischemic insult. Nuclear Factor-kappaB (NF-kappaB) activation occurs following IPC in brain. 1 However, the upstream signaling messengers and down-stream targets of NF-kappaB required for induction of IPC remain undefined. Previously, we demonstrated that epsilon protein kinase c (ePKC) is the key mediator of IPC-and ePKC-induced cyclooygenase-2 (COX-2) expression in the in vitro models. 2 Here, we hypothesized that IPC-mediated COX-2 expression was regulated by NF-kappaB. Method: Mixed cortical neuron/astrocyte cell cultures were prepared from rat embryo/neonatal rat (18-19/1-2 days old), respectively. To simulate preconditioning or ischemia, cell cultures were exposed to 1 h or 4 h of oxygen-glucose deprivation (OGD), respectively. Epsilon PKC agonist peptide (100 nmol/L) was applied to cell culture for 1 h. Cell lysates were isolated at different time points after IPC or ePKC agonist treatment for immunoblotting with antibody against p65 and p50 subunits of NF-kappaB. Objective: Hyperbaric oxygen (HBO) therapy is an accepted treatment alternative for preconditioning in both focal 1 and global 2 cerebral ischemia. Medical ozone therapy, a new therapeutic approach, has been reported similar molecular mechanisms to HBO in ischemic conditions. 3 One mechanism of the protective effects of HBO against central nervous system ischemia was explained with heme oxygenase-1 (HO-1) induction. 4 Interestingly, HO-1 is also known to play role in ozone/oxygen applications 3 and seems to be an intersection point among these two treatment modalities. 5 In the present study we compared HBO and ozone/oxygen pretreatments in the 2-VO rat model. 6 Methods: Sprague-Dawley rats were divided into 4 groups: control, global ischemia, HBO and ozone/ oxygen. HBO was administered one time a day at 2,5 atmosphere/1,5 h sessions. Daily intraperitoneally ozone/oxygen (5%/95%) injections at a dose estimated to supply 0.7 mg/kg-BW of ozone. Twentyfour hours after the third applications of HBO or ozone/ oxygen, global cerebral ischemia (GI) was induced via bilateral carotid artery occlusion for 10 min. Prior to sacrificing, the neurological deficit was evaluated by a blinded expert usind the Garcia score. 7 The rats were then sacrificed 24 h following GI induction and their brains were taken for for histopathological Figure 1 Representative photos of Nissl-stained slices. evaluation, namely Nissl and Tunel staining, and determination of HO-1 mRNA expression. Results: Functional evaluation according to Garcia's method resulted with comparable scores; only a slight but insignificant improvement was observed. HO-1 was found to be depressed in GI group, whereas both HBO and ozone/oxygen treatments induced increased transcripton of HO-1 mRNA with nearly the same rates. In the Nissl-stained slices, neuronal tissue loss was apparent in the hippocampal and cortical regions of GI animals. Pretreatment with HBO was able to reduce this injury, whereas in ozone/oxygen treated animals more protection was observed. Strong TUNEL-positive staining appeared in the hippocampus and cortex after GI. Both HBO and ozone/oxygen pretreatment reduced TUNEL-positive staining in neuronal tissue, of which ozone/oxygen mixture was significantly more effective.
Conclusion:
The present findings suggest that pretreatment with ozone/oxygen mixture, at least from the histopathological viewpoint, may exert more satisfying outcome than HBO. Therefore, this new treatment modality have to be taken into consideration and further detailed studies have to be performed on this area. Grant: This study was supported by the Gulhane Military Medical Academy Research and Progress Center with the grant Nr.AR-2003/56.
